Table 1 HHV-8, CMV and EBV seropositivity according to age and gender among the 3275 HIV-seronegative healthy blood donors in Ghana
From: Seroprevalence of HHV-8, CMV, and EBV among the general population in Ghana, West Africa
Age group, years | Proportion (%) of HIV-seronegative blood donors with HHV8 seropositivity | Proportion (%) of HIV-seronegative blood donors with CMV seropositivity | Proportion (%) of HIV-seronegative blood donors with EBV seropositivity | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Â | Male | Female | All | Male | Female | All | Male | Female | All |
16–25 | 104/681 (15.3) | 65/335 (19.4) | 169/1016 (16.6) | 558/681 (81.9) | 232/335 (69.3) | 790/1016 (77.8) | 108/681 (15.9) | 74/335 (22.1) | 182/1016 (17.9) |
26–35 | 241/1120 (21.5) | 88/220 (40.0) | 329/1340 (24.6) | 831/1120 (74.2) | 158/220 (71.8) | 989/1340 (73.8) | 35/1120 (3.1) | 28/220 (12.7) | 63/1340 (4.7) |
36–45 | 118/478 (24.7) | 29/74 (39.2) | 147/552 (26.6) | 423/478 (88.5) | 57/74 (77.0) | 480/552 (87.0) | 223/478 (46.7) | 36/74 (48.6) | 259/552 (46.9) |
46–55 | 48/158 (30.4) | 12/42 (28.6) | 60/200 (30.0) | 101/158 (63.9) | 37/42 (88.1) | 138/200 (69.0) | 76/158 (48.1) | 18/42 (42.9) | 94/200 (47.0) |
56–65 | 56/136 (41.2) | 16/31 (51.6) | 72/167 (43.1) | 120/136 (88.2) | 25/31 (80.6) | 145/167 (86.8) | 40/136 (29.4) | 18/31 (58.1) | 58/167 (34.7) |
Total | 567/2573 (22.0) | 210/702 (29.9) | 777/3275 (23.7) | 2033/2573 (79.0) | 509/702 (72.5) | 2542/3275 (77.6) | 482/2573 (18.7) | 174/702 (24.8) | 656/3275 (20.0) |